We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
426
DELISTED
Discover Financial Services
DFS
| $26M | 0.03% |
152,139
+6,814
| +5% | +$1.25M |
|
427
Baker Hughes
BKR
$63B
| $25.9M | 0.03% |
589,044
-13,800
| -2% | -$616K |
|
428
American International
AIG
$39.8B
| $25.8M | 0.03% |
297,090
+1,379
| +0.5% | +$107K |
|
|
RNAM
429
DELISTED
Avidity Biosciences
RNAM
| $25.8M | 0.03% |
873,222
+74,194
| +9% | +$2.31M |
|
430
Interparfums
IPAR
$3.73B
| $25.7M | 0.03% |
225,627
-115,001
| -34% | -$15.3M |
|
431
Charter Communications
CHTR
$18.7B
| $25.6M | 0.03% |
69,550
+12,881
| +23% | +$4.61M |
|
432
Monster Beverage
MNST
$91.3B
| $25.6M | 0.03% |
874,908
+236,570
| +37% | +$6.17M |
|
433
Fidelity National Information Services
FIS
$22.5B
| $25.6M | 0.03% |
342,691
+3,030
| +0.9% | +$228K |
|
434
Jazz Pharmaceuticals
JAZZ
$15.9B
| $25.5M | 0.03% |
207,640
-4,080
| -2% | -$532K |
|
435
Realty Income
O
$59.7B
| $25.4M | 0.03% |
437,954
-78,794
| -15% | -$4.36M |
|
436
EOG Resources
EOG
$74.2B
| $25.3M | 0.03% |
197,104
-1,310
| -0.7% | -$169K |
|
437
Emcor
EME
$36.9B
| $25.3M | 0.03% |
68,363
+5,580
| +9% | +$2.41M |
|
438
Kiniksa Pharmaceuticals
KNSA
$6.04B
| $25.2M | 0.03% |
1,133,931
| – | – |
|
439
T. Rowe Price
TROW
$23.8B
| $25.1M | 0.03% |
273,568
+61,600
| +29% | +$6.51M |
|
440
Willis Towers Watson
WTW
$31.1B
| $25M | 0.03% |
74,078
-7,757
| -9% | -$2.53M |
|
441
Nasdaq
NDAQ
$54.3B
| $24.8M | 0.03% |
326,983
+38,230
| +13% | +$3.01M |
|
442
AvalonBay Communities
AVB
$26.3B
| $24.8M | 0.03% |
115,461
-4,433
| -4% | -$962K |
|
443
CBRE Group
CBRE
$43.8B
| $24.7M | 0.03% |
188,642
-2,299
| -1% | -$312K |
|
444
NetApp
NTAP
$40.5B
| $24.6M | 0.03% |
279,870
-10,647
| -4% | -$1.18M |
|
445
Consolidated Edison
ED
$40B
| $24.6M | 0.03% |
222,152
+2,557
| +1% | +$251K |
|
446
Keurig Dr Pepper
KDP
$42.1B
| $24.5M | 0.03% |
716,269
+39,540
| +6% | +$1.28M |
|
447
Public Storage
PSA
$61.1B
| $24.5M | 0.03% |
81,875
-25,648
| -24% | -$7.67M |
|
448
Ferrovial N.V. Ordinary Shares
FER
$46.5B
| $24.5M | 0.03% |
555,171
-19,444
| -3% | -$838K |
|
449
MetLife
MET
$61.7B
| $24.5M | 0.03% |
304,602
+10,648
| +4% | +$886K |
|
450
Essent Group
ESNT
$6.2B
| $24.3M | 0.03% |
421,245
-113,647
| -21% | -$6.44M |
|
Similar funds
VAM
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.